BACULOVIRUS-MEDIATED EXPRESSION OF THE EPIDERMAL GROWTH FACTOR-LIKE MODULES OF HUMAN FACTOR-IX FUSED TO THE FACTOR-XIIIA TRANSAMIDATION SITE IN FIBRONECTIN - EVIDENCE FOR A DIRECT INTERACTION BETWEEN THE NH(2)-TERMINAL EPIDERMAL GROWTH FACTOR-LIKE MODULE OF FACTOR-IXA-BETA AND FACTOR-X
J. Astermark et al., BACULOVIRUS-MEDIATED EXPRESSION OF THE EPIDERMAL GROWTH FACTOR-LIKE MODULES OF HUMAN FACTOR-IX FUSED TO THE FACTOR-XIIIA TRANSAMIDATION SITE IN FIBRONECTIN - EVIDENCE FOR A DIRECT INTERACTION BETWEEN THE NH(2)-TERMINAL EPIDERMAL GROWTH FACTOR-LIKE MODULE OF FACTOR-IXA-BETA AND FACTOR-X, The Journal of biological chemistry, 269(5), 1994, pp. 3690-3697
Factor IX is a vitamin K-dependent procoagulant zymogen of a serine pr
otease. In the presence of Ca2+ the active form of factor IX (factor I
Xabeta) forms a complex with factor VIIIa on suitable phospholipid sur
faces such as aggregated platelets. This macromolecular complex rapidl
y activates factor X. We have previously provided data that suggest an
interaction between the NH2-terminal epidermal growth factor (EGF)-li
ke module of factor IXabeta and the substrate factor X. In an alternat
ive approach to study this protein-protein interaction, we have expres
sed three recombinant baculovirus constructs encoding the EGF-like mod
ules of human factor IX and a truncated form of fibronectin in a syste
m based on the infection of insect cells (Spodoptera frugiperda 21). T
his strategy allows a simple one-step purification of the recombinant
proteins on a gelatin-Sepharose column, followed by removal of the gel
atin-binding part derived from fibronectin by proteolytic cleavage. Th
e fusion proteins were isolated at yields of 20-50 mug/ml culture medi
um. The recombinant EGF-like modules contained 0.2-0.4 mol of erythro-
beta-hydroxyaspartic acid/mol of protein, i.e. similar to the amount f
ound in factor IX from human plasma, and appeared to be glycosylated a
t Ser-53. The NH2-terminal EGF-like module, which contained a transami
dation acceptor site derived from ribronectin, was cross-linked by fac
tor Xllla in solution to intact and Gla-domainless factor X. There was
no evidence of cross-linking to activated factor X or to factor X fra
gments containing only the gamma-carboxyglutamic acid module and the t
wo EGF-like modules. The cross-linking results suggest a specific inte
raction between the NH2-terminal EGF-like module of factor IXabeta and
the heavy chain of unactivated factor X. This interaction, albeit wea
k as judged by competition experiments, may be important for the targe
ting of factor X to the factor IXabeta-factor VIIIa complex on biologi
cal membranes and for the subsequent dissociation of factor Xa from th
e complex after activation.